Table 4.
Group | IL-10 | IL-17A | TNF | IFN-γ | IL-6 | IL-4 | IL-2 |
---|---|---|---|---|---|---|---|
Blank | 13.32 ± 1.83 | 1.96 ± 0.20 | 8.94 ± 0.72 | 2.45 ± 0.41 | 5.32 ± 1.68 | 5.74 ± 1.27 | 2.27 ± 1.83 |
DBS100 | 8.95 ± 1.01∗ | 3.93 ± 0.58∗ | 14.25 ± 2.74∗ | 7.57 ± 1.92∗ | 19.12 ± 1.98∗∗ | ≦0 | 6.65 ± 2.5∗∗ |
LOW | 12.37 ± 1.75 | 2.17 ± 1.28 | 8.07 ± 0.82 | 2.13 ± 0.27 | 5.67 ± 1.37 | ≦0 | 3.2 ± 2.12 |
LOW + DBS100 | 8.07 ± 1.00∗∗ | 4.18 ± 0.76∗ | 15.21 ± 1.59∗∗ | 7.90 ± 2.80∗ | 21.36 ± 4.54∗∗ | 4.13 ± 2.02 | 8.78 ± 1.75∗∗ |
MED | 12.53 ± 1.89 | 2.12 ± 0.52 | 9.35 ± 0.78 | 2.41 ± 0.19 | 5.52 ± 1.24 | ≦0 | 2.68 ± 1.62 |
MED + DBS100 | 6.45 ± 1.55∗∗ | 4.65 ± 0.36∗∗ | 16.17 ± 2.75∗∗ | 11.50 ± 1.69∗∗ | 26.43 ± 3.84∗∗ | 3.49 ± 1.67 | 8.16 ± 3.04∗∗ |
HIG | 11.44 ± 1.70 | 2.31 ± 0.61 | 9.11 ± 2.13 | 2.28 ± 0.36 | 5.53 ± 1.73 | ≦0 | 2.21 ± 2.44 |
HIG + DBS100 | 4.61 ± 0.67∗∗# | 5.97 ± 1.47∗∗# | 20.96 ± 1.76∗∗## | 14.56 ± 1.67∗∗## | 34.06 ± 5.26∗∗## | 1.54 ± 1.32 | 12.49 ± 2.66∗∗## |
Notes: ∗ P < 0.05, compared with the blank group. ∗∗ P < 0.01, compared with the blank group. # P < 0.05, compared with the DBS100 treated alone group. ## P < 0.01, compared with the DBS100 treated alone group.